57: Understanding Treatment Options for Acute Myeloid Leukemia

<div>Acute myeloid leukemia (AML), a blood cancer that starts in the bone marrow, accounts for almost 20,000 new cases of cancer, according to the American Cancer Society.</div> <div> </div> <div>It is one of the most common types of leukemias in adults; however, the disease comprises only about 1% of all cancers.</div> <div> </div> <div>There are a variety of treatment options available for patients with AML, with more clinical trials evaluating new therapies in the pipeline. In this episode of the “<em>CURE</em> talks Cancer” podcast, we spoke with Dr. Dan Pollyea, from the University of Colorado School of Medicine, about these treatment options.</div>